Table 2.
Group | n | Dose (g kg−1) | CIA (%) |
---|---|---|---|
SG | 15 | – | 0.0 ± 0.0** |
MG | 8 | – | 28.05 ± 4.97 |
NMP | 9 | 0.02 | 13.04 ± 5.46** |
NLT | 9 | 0.5 | 15.46 ± 7.29** |
10:0 | 8 | ATS:VTG = 0.2:0 | 16.16 ± 8.95** |
8:2 | 8 | ATS:VTG = 0.16:0.04 | 17.75 ± 9.55* |
7:3 | 9 | ATS:VTG = 0.14:0.06 | 12.96 ± 6.89** |
6:4 | 9 | ATS:VTG = 0.12:0.08 | 15.84 ± 9.36** |
5:5 | 10 | ATS:VTG = 0.1:0.1 | 15.08 ± 9.69** |
4:6 | 9 | ATS:VTG = 0.08:0.12 | 15.50 ± 6.76** |
3:7 | 8 | ATS:VTG = 0.06:0.14 | 16.63 ± 8.92** |
2:8 | 8 | ATS:VTG = 0.04:0.16 | 17.38 ± 10.18** |
0:10 | 8 | ATS:VTG = 0:0.2 | 20.05 ± 10.10* |
Note: Compared to the model group.
P < 0.05.
P < 0.01.